Yang Li

Title: Yang Li - Innovator in Collagen Targeting Technology

Introduction

Yang Li is a noted inventor based in Baltimore, MD, who has made significant contributions to the field of biomedical imaging and therapeutic applications. His pioneering work in collagen mimetic peptides has the potential to enhance the effectiveness of diagnostic and therapeutic methodologies.

Latest Patents

Yang Li holds one patent titled “Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic use.” This innovative invention focuses on a caged collagen mimetic peptide (CCMP) designed to bind with collagen and denatured collagen, making it highly useful in clinical research, diagnostic imaging, and therapeutic applications. The formulation includes detectable moieties, spacer molecules, and is intended for targeting tissues where collagen is present.

Career Highlights

Yang Li is affiliated with The Johns Hopkins University, where he has been instrumental in advancing research that bridges the gap between innovative biomedical technologies and practical application. His work exemplifies the integration of scientific research with healthcare solutions.

Collaborations

Li works alongside talented colleagues such as Michael S. Yu and Daniel Summerfield, reflecting a collaborative environment that fosters innovation. Together, they contribute to groundbreaking research in their respective fields, enhancing the scope and impact of their work.

Conclusion

Yang Li stands out as an innovative inventor whose work with collagen mimetic peptides indicates a promising future in the realm of medical research and applications. His dedication to discovery offers new possibilities for enhancing diagnostic techniques and therapeutic strategies in healthcare.